A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

NCT06664502 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema (DME)
Neovascular Age-related Macular Degeneration (NVAMD)
BRVO - Branch Retinal Vein Occlusion

Interventions

DRUG: EYE201

Sponsor

EyeBiotech Ltd.